SI0659414T1 - Inhibition of hirsutism and alopecia in women - Google Patents

Inhibition of hirsutism and alopecia in women

Info

Publication number
SI0659414T1
SI0659414T1 SI9430389T SI9430389T SI0659414T1 SI 0659414 T1 SI0659414 T1 SI 0659414T1 SI 9430389 T SI9430389 T SI 9430389T SI 9430389 T SI9430389 T SI 9430389T SI 0659414 T1 SI0659414 T1 SI 0659414T1
Authority
SI
Slovenia
Prior art keywords
alopecia
women
hirsutism
inhibition
chem
Prior art date
Application number
SI9430389T
Other languages
English (en)
Inventor
George Joseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SI0659414T1 publication Critical patent/SI0659414T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
SI9430389T 1993-12-21 1994-12-19 Inhibition of hirsutism and alopecia in women SI0659414T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/171,089 US5574048A (en) 1993-12-21 1993-12-21 Methods of inhibiting hirsutism and alopecia in women
EP94309471A EP0659414B1 (en) 1993-12-21 1994-12-19 Inhibition of hirsutism and alopecia in women

Publications (1)

Publication Number Publication Date
SI0659414T1 true SI0659414T1 (en) 2001-12-31

Family

ID=22622479

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9430389T SI0659414T1 (en) 1993-12-21 1994-12-19 Inhibition of hirsutism and alopecia in women

Country Status (22)

Country Link
US (2) US5574048A (ja)
EP (1) EP0659414B1 (ja)
JP (1) JPH07215864A (ja)
KR (1) KR950016728A (ja)
CN (1) CN1107703A (ja)
AT (1) ATE203406T1 (ja)
AU (1) AU690162B2 (ja)
CA (1) CA2138498A1 (ja)
CZ (1) CZ321394A3 (ja)
DE (1) DE69427807T2 (ja)
DK (1) DK0659414T3 (ja)
ES (1) ES2157961T3 (ja)
GR (1) GR3036977T3 (ja)
HU (1) HUT71479A (ja)
IL (1) IL112040A0 (ja)
NO (1) NO944920L (ja)
NZ (1) NZ270171A (ja)
PH (1) PH31440A (ja)
PT (1) PT659414E (ja)
RU (1) RU94044457A (ja)
SI (1) SI0659414T1 (ja)
ZA (1) ZA9410092B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965551A (en) 1996-02-21 1999-10-12 North Carolina State University Method of treating alopecia
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
TW442286B (en) * 1996-02-28 2001-06-23 Pfizer New therapeutic uses of estrogen agonists
HUP0200871A3 (en) 1999-05-04 2004-04-28 Strakan Int Ltd Androgen glycosides and androgenic activity thereof
US20060263452A1 (en) * 2005-05-17 2006-11-23 Alwyn Dowell Topical composition containing essential oils
EP3871671A3 (en) 2009-07-29 2022-03-09 Olsen, Elise Fp receptor antagonists for inhibiting hair growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4859585A (en) * 1986-04-17 1989-08-22 Trustees Of Tufts College In-vitro methods for identifying compositions which are agonists and antagonists of estrogens
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体

Also Published As

Publication number Publication date
DK0659414T3 (da) 2001-09-24
AU690162B2 (en) 1998-04-23
JPH07215864A (ja) 1995-08-15
NZ270171A (en) 1996-08-27
GR3036977T3 (en) 2002-01-31
HU9403665D0 (en) 1995-02-28
US5686468A (en) 1997-11-11
PT659414E (pt) 2001-11-30
DE69427807D1 (de) 2001-08-30
US5574048A (en) 1996-11-12
HUT71479A (en) 1995-11-28
CN1107703A (zh) 1995-09-06
KR950016728A (ko) 1995-07-20
IL112040A0 (en) 1995-03-15
ATE203406T1 (de) 2001-08-15
AU8155094A (en) 1995-06-29
ES2157961T3 (es) 2001-09-01
CA2138498A1 (en) 1995-06-22
DE69427807T2 (de) 2001-12-06
CZ321394A3 (en) 1995-08-16
RU94044457A (ru) 1996-10-10
PH31440A (en) 1998-11-03
NO944920L (no) 1995-06-22
NO944920D0 (no) 1994-12-19
EP0659414A3 (en) 1995-09-06
EP0659414B1 (en) 2001-07-25
EP0659414A2 (en) 1995-06-28
ZA9410092B (en) 1996-06-19

Similar Documents

Publication Publication Date Title
GR3023537T3 (en) Inhibition of thrombin.
SG43319A1 (en) Methods for inhibiting endometriosis
GR3023378T3 (en) Inhibition of seborrhea and acne.
ZA948027B (en) Methods for inhibiting angiogenesis and angiogenic diseases
ZA9410094B (en) Method of increasing libido in post-menopausal women
EP0659413A3 (en) Inhibiting CNS problems in postmenopausal women.
SI0659414T1 (en) Inhibition of hirsutism and alopecia in women